Skip to main
BLLN
BLLN logo

Billiontoone Inc (BLLN) Stock Forecast & Price Target

Billiontoone Inc (BLLN) Analyst Ratings

Based on 6 analyst ratings
Buy
Strong Buy 33%
Buy 33%
Hold 33%
Sell 0%
Strong Sell 0%

Bulls say

BillionToOne Inc. has demonstrated significant financial growth, achieving a remarkable increase in gross margins to 53.0% alongside an impressive year-over-year revenue growth of 117% in its first quarter as a public company. The company's prenatal test revenue surged to $74.1 million, reflecting a 102% increase, while oncology revenue reached $8.7 million with an astounding 664% year-over-year growth, indicating strong demand for its innovative diagnostic solutions. Furthermore, with a positive net income of $1.5 million and the potential for increased tests per patient, BillionToOne is well-positioned for continued revenue growth in the reproductive health market, projecting a compound annual growth rate (CAGR) of over 25%.

Bears say

BillionToOne Inc faces potential challenges that could adversely impact its financial performance, including the risk of weakening competitive position if its proprietary technology is not adequately protected. The company's revenue may decline due to anticipated decreases in reimbursement rates under the Clinical Lab Fee Schedule (CLFS) and heightened denial rates from payers due to questions regarding the efficacy of its tests. Additionally, slower revenue growth from its core prenatal testing business and newly launched oncology tests, combined with risks related to reimbursement from Medicare and Medicaid, further contribute to an uncertain outlook for BillionToOne's financial stability.

Billiontoone Inc (BLLN) has been analyzed by 6 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 33% recommend Buy, 33% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Billiontoone Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Billiontoone Inc (BLLN) Forecast

Analysts have given Billiontoone Inc (BLLN) a Buy based on their latest research and market trends.

According to 6 analysts, Billiontoone Inc (BLLN) has a Buy consensus rating as of Dec 13, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $137.83, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $137.83, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Billiontoone Inc (BLLN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.